Incannex Healthcare Inc. (NASDAQ: IXHL) Stock Information | RedChip

Incannex Healthcare Inc. (NASDAQ: IXHL)


$2.57
+0.0200 ( +0.78% ) 28.1K

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Market Data


Open


$2.57

Previous close


$2.55

Volume


28.1K

Market cap


$44.81M

Day range


$2.39 - $2.67

52 week range


$0.80 - $12.68

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 Nov 20, 2023
6-k Quarterly Reports 3 Nov 17, 2023
6-k Quarterly Reports 30 Nov 17, 2023
6-k Quarterly Reports 5 Nov 16, 2023
6-k Quarterly Reports 5 Nov 08, 2023
6-k Quarterly Reports 2 Nov 07, 2023
20-f Annual reports 154 Oct 31, 2023
6-k Quarterly Reports 4 Oct 26, 2023
6-k Quarterly Reports 5 Oct 19, 2023
6-k Quarterly Reports 11 Oct 10, 2023

Latest News